Pollution Engineering Magazine
  Resources
  Archives
  Digital Edition Archives
  Buyers Guide
  Classified Ads
  White Papers
  Industry Links
  Market Research
  Career Center
  Resource Guide
  Current Issue
  Cover Story
  Features
  Columns
  Industry News
  PE Info
  Contact Us
  Media Kit
  About
  Online
  PE Coffeehaus
  PE Partner Blogs
  eNewsletters
  Calendar
  ePE-TV
  Webinars
  Podcast
  PE Learning Center
Search in: EditorialProductsCompanies
Report on Maine's Pharmaceutical Mail-back Pilot

May 25, 2010

ARTICLE TOOLS
EmailEmailPrintPrintReprintsReprintsshareShare



Through a grant awarded by the EPA, the University of Maine's Center on Aging has completed a statewide mail-back pilot program for managing pharmaceutical waste from consumers. The program included the use of mailers to return unused and unwanted medications, both prescription and over-the-counter, from households.

Maine Care (Maine's Medicaid program) established a limit for certain drugs on the quantity that can be filled with an initial prescription. This policy was targeted at reducing the supply and accumulation of unused medications and to prevent pollution. The Maine legislature also recognized the value of the take-back pilot and enacted legislation to continue the program for an additional two years. As part of the EPA grant, the University of Maine's Center on Aging developed a handbook on the project and collected data on the type and amount of unused medications.

"This pilot is important because it has filled research gaps about the volumes and types of medications that can end up in our waters, and affect our ecosystems," said Peter S. Silva, assistant administrator for EPA's Office of Water. "The pilot also gave residents a way to serve as environmental stewards to reduce water pollution."

A 2005 report by the Associate Press opened the door for pharmaceuticals to possibly be regulated or treated in drinking water, as the article showed more than trace amounts of drugs were present in our nation's waterbodies. The EPA is currently evaluating the potential risks associated with pharmaceuticals and personal care products on public health and aquatic life, but controls seem a long way off.

View the executive summary of the report at www.epa.gov/aging/RX-report-Exe-Sum/.

SOURCES: University of Maine Center on Aging Press Release, EPA Press Release


|PrintEmail

Did you enjoy this article? Click here to subscribe to the magazine.











BNP Media
© 2010 BNP Media. All rights reserved. | Privacy Policy